Prevalence of clinically significant depression in adults with diabetes: controlled studies (n = 20)
Study . | Subjects (Diabetic: n) (Control: n) . | Sex (% female) . | Age (years) . | Race (% white) . | Depression assessment method . | Prevalence of depression . | Depression scale scores . | ||
---|---|---|---|---|---|---|---|---|---|
Overall (%) . | Males (%) . | Females (%) . | |||||||
Kokkonen (62) | T1: 63e | 41.3 | 20.9 ± 1.9 | — | PSE ID ≥5 | 14.3 | — | — | Men: 9.3 ± 9.4* Women: 14.2 ± 10.2 |
Medically well: 123a | 51.2 | 21.9 ± 1.4 | — | 11.4† | — | — | — | ||
Songar et al. (25) | T1: 60e | 68.3 | 29.7 | — | BDI ≥14 | 43.3 | — | — | 15.2 |
Medically well: 30c | 60.0 | 29.2 | — | 3.3* | — | — | 4.1* | ||
Popkin et al. (63) | T1: 75e | 64.0 | 31 | — | DIS/DSM-III | 10.7 | 3.7 | 14.6 | — |
1st degree relatives: 34f | 55.9 | 36 | — | 2.9† | 0.0† | 5.3† | — | ||
Amato et al. (64) | T2: 197a | 68.0 | 73.9 ± 5.9 | — | GDS ≥21 | 13.6 | 11.4 | 14.7 | 13.2 ± 6.8 |
1142a | 55.9 | 74.2 ± 6.4 | — | 8.7‡ | 6.6* | 10.6§ | 11.1 ± 6.5* | ||
Eaton et al. (50) | T2: 148a | — | — | — | DIS/DSM | 6.1 | — | — | — |
1600a | — | — | — | 5.3† | — | — | — | ||
Viinamäki et al. (65) | T2: 82a | 46.3 | 66.9 ± 0.7 | — | Zung ≥50 | 11.0 | 11.4 | 10.5 | 39.4 ± 1.3 |
115a | 55.7 | 65.6 ± 0.5 | — | 6.9† | — | — | 36.9 ± 0.8† | ||
Leedom et al. (26) | T2: 71e | 70.4 | 50 ± 2.0 | 18.3 | BDI ≥10 | 49.3 | — | — | 12.2 |
46e | 67.4 | 46 ± 1.7 | 23.9 | 21.7§ | — | — | 5.9 ± 0.7 | ||
Palinkas et al. (28) | T2: 93a | 39.8 | 72.4 ± 8.7 | — | BDI ≥13 | 11.5 | 8.8 | 13.6 | 6.5 |
1284a | 54.5 | 68.5 ± 9.5 | — | 4.6‡‖ | 2.6‡¶ | 6.2†¶ | 5.4§‖ | ||
Wing et al. (29) | T2: 32e | 50.0 | 52.1 ± 7.7 | — | BDI ≥16 | 21.8 | — | — | 10.6 ± 6.4 |
Spouses: 32e | 50.0 | 50.8 ± 8.8 | — | 12.5† | — | — | 7.5 ± 6.2‡ | ||
Weyerer et al. (66) | T2: 55a | 72.7 | — | — | CIS/ICD 8 | 27.3 | — | — | — |
Medically well: 122a | 54.1 | — | — | 10.6§‖ | — | — | — | ||
Tun et al. (32)# | T2: 119e | 48.7 | 63.4 | — | Zung## | — | — | — | 39.3 |
Nondiabetic out-patients: 25e | 56.0 | 63.0 | — | — | — | — | 34.0§ | ||
Black (67) | T1 & 2: 636a | 58.2 | — | 0.0 | CES-D ≥16 | 31.1 | 22.6 | 37.9 | — |
2196a | 58.4 | — | 0.0 | 24.1* | 15.9§ | 30.2§ | — | ||
Penninx et al. (33)# | T1 & 2: 204a | 52.9 | 73.3 ± 7.7 | — | CES-D## | — | — | — | 10.1 ± 9.2 |
Medically well: 719a | 42.4 | 67.2 ± 8.6 | — | — | — | — | 5.4 ± 6.3* | ||
Bourdel-Marchasson et al. (68) | T1 & 2: 237a | 50.6 | — | — | CES-D Men: ≥17 Women: ≥23 | 21.3 | — | — | Men: 9.3 ± 9.4* Women: 14.2 ± 10.2 |
2555a | 60.7 | — | — | 12.7*†† | — | — | Men: 7.2 ± 7.6§§ Women: 11.8 ± 9.6 | ||
Rajala et al. (69) | T1 & 2: 62a | 40.3 | 55 | — | Zung ≥45 | 19.3 | 18.9 | 20.0 | — |
480a | 58.5 | 55 | — | 11.7† | 10.1† | 12.8† | — | ||
Zhang et al. (70) | T1 & 2: 209a | 58.4 | — | 0.0 | DIS/DSM-III + CES-D | 3.8¶ | 1.8¶ | 5.1¶ | 8.3¶ |
1289a | 55.6 | — | 0.0 | 3.6†¶ | 1.7†¶ | 5.1†¶ | 7.8†¶ | ||
Wells et al. (71) | T1 & 2: 154a‖‖ | — | — | — | DIS/DSM-III | 9.6 | — | — | — |
Medically well: 1353a‖‖ | — | — | 48.5¶¶ | 4.4† | — | — | — | ||
Robinson et al. (72) | T1 & 2: 60:70e | 45.4 | 51 ± 6.6 | 56.9 | PSE/Bedford Col. criteria | 8.5 | — | — | — |
130f | 45.4 | 44 ± 10.4 | 72.3 | 8.5† | — | — | — | ||
Friis et al. (73) | T1 & 2: 56b | 71.4 | 57.0 | 60.7 | CES-D ≥16 | 60.7 | — | — | 20.4 |
Medically ill: 56b | 73.2 | 53.0 | 63.2 | 48.2† | — | — | 14.2‡ | ||
Murrell et al. (74) | T1 & 2: 175a | 65.7 | — | 92.9¶¶ | CES-D ≥20 | 21.7 | 15.5 | 25.4 | — |
2277a | 61.5 | — | — | 16.0‡ | 13.4 | 17.6 | — |
Study . | Subjects (Diabetic: n) (Control: n) . | Sex (% female) . | Age (years) . | Race (% white) . | Depression assessment method . | Prevalence of depression . | Depression scale scores . | ||
---|---|---|---|---|---|---|---|---|---|
Overall (%) . | Males (%) . | Females (%) . | |||||||
Kokkonen (62) | T1: 63e | 41.3 | 20.9 ± 1.9 | — | PSE ID ≥5 | 14.3 | — | — | Men: 9.3 ± 9.4* Women: 14.2 ± 10.2 |
Medically well: 123a | 51.2 | 21.9 ± 1.4 | — | 11.4† | — | — | — | ||
Songar et al. (25) | T1: 60e | 68.3 | 29.7 | — | BDI ≥14 | 43.3 | — | — | 15.2 |
Medically well: 30c | 60.0 | 29.2 | — | 3.3* | — | — | 4.1* | ||
Popkin et al. (63) | T1: 75e | 64.0 | 31 | — | DIS/DSM-III | 10.7 | 3.7 | 14.6 | — |
1st degree relatives: 34f | 55.9 | 36 | — | 2.9† | 0.0† | 5.3† | — | ||
Amato et al. (64) | T2: 197a | 68.0 | 73.9 ± 5.9 | — | GDS ≥21 | 13.6 | 11.4 | 14.7 | 13.2 ± 6.8 |
1142a | 55.9 | 74.2 ± 6.4 | — | 8.7‡ | 6.6* | 10.6§ | 11.1 ± 6.5* | ||
Eaton et al. (50) | T2: 148a | — | — | — | DIS/DSM | 6.1 | — | — | — |
1600a | — | — | — | 5.3† | — | — | — | ||
Viinamäki et al. (65) | T2: 82a | 46.3 | 66.9 ± 0.7 | — | Zung ≥50 | 11.0 | 11.4 | 10.5 | 39.4 ± 1.3 |
115a | 55.7 | 65.6 ± 0.5 | — | 6.9† | — | — | 36.9 ± 0.8† | ||
Leedom et al. (26) | T2: 71e | 70.4 | 50 ± 2.0 | 18.3 | BDI ≥10 | 49.3 | — | — | 12.2 |
46e | 67.4 | 46 ± 1.7 | 23.9 | 21.7§ | — | — | 5.9 ± 0.7 | ||
Palinkas et al. (28) | T2: 93a | 39.8 | 72.4 ± 8.7 | — | BDI ≥13 | 11.5 | 8.8 | 13.6 | 6.5 |
1284a | 54.5 | 68.5 ± 9.5 | — | 4.6‡‖ | 2.6‡¶ | 6.2†¶ | 5.4§‖ | ||
Wing et al. (29) | T2: 32e | 50.0 | 52.1 ± 7.7 | — | BDI ≥16 | 21.8 | — | — | 10.6 ± 6.4 |
Spouses: 32e | 50.0 | 50.8 ± 8.8 | — | 12.5† | — | — | 7.5 ± 6.2‡ | ||
Weyerer et al. (66) | T2: 55a | 72.7 | — | — | CIS/ICD 8 | 27.3 | — | — | — |
Medically well: 122a | 54.1 | — | — | 10.6§‖ | — | — | — | ||
Tun et al. (32)# | T2: 119e | 48.7 | 63.4 | — | Zung## | — | — | — | 39.3 |
Nondiabetic out-patients: 25e | 56.0 | 63.0 | — | — | — | — | 34.0§ | ||
Black (67) | T1 & 2: 636a | 58.2 | — | 0.0 | CES-D ≥16 | 31.1 | 22.6 | 37.9 | — |
2196a | 58.4 | — | 0.0 | 24.1* | 15.9§ | 30.2§ | — | ||
Penninx et al. (33)# | T1 & 2: 204a | 52.9 | 73.3 ± 7.7 | — | CES-D## | — | — | — | 10.1 ± 9.2 |
Medically well: 719a | 42.4 | 67.2 ± 8.6 | — | — | — | — | 5.4 ± 6.3* | ||
Bourdel-Marchasson et al. (68) | T1 & 2: 237a | 50.6 | — | — | CES-D Men: ≥17 Women: ≥23 | 21.3 | — | — | Men: 9.3 ± 9.4* Women: 14.2 ± 10.2 |
2555a | 60.7 | — | — | 12.7*†† | — | — | Men: 7.2 ± 7.6§§ Women: 11.8 ± 9.6 | ||
Rajala et al. (69) | T1 & 2: 62a | 40.3 | 55 | — | Zung ≥45 | 19.3 | 18.9 | 20.0 | — |
480a | 58.5 | 55 | — | 11.7† | 10.1† | 12.8† | — | ||
Zhang et al. (70) | T1 & 2: 209a | 58.4 | — | 0.0 | DIS/DSM-III + CES-D | 3.8¶ | 1.8¶ | 5.1¶ | 8.3¶ |
1289a | 55.6 | — | 0.0 | 3.6†¶ | 1.7†¶ | 5.1†¶ | 7.8†¶ | ||
Wells et al. (71) | T1 & 2: 154a‖‖ | — | — | — | DIS/DSM-III | 9.6 | — | — | — |
Medically well: 1353a‖‖ | — | — | 48.5¶¶ | 4.4† | — | — | — | ||
Robinson et al. (72) | T1 & 2: 60:70e | 45.4 | 51 ± 6.6 | 56.9 | PSE/Bedford Col. criteria | 8.5 | — | — | — |
130f | 45.4 | 44 ± 10.4 | 72.3 | 8.5† | — | — | — | ||
Friis et al. (73) | T1 & 2: 56b | 71.4 | 57.0 | 60.7 | CES-D ≥16 | 60.7 | — | — | 20.4 |
Medically ill: 56b | 73.2 | 53.0 | 63.2 | 48.2† | — | — | 14.2‡ | ||
Murrell et al. (74) | T1 & 2: 175a | 65.7 | — | 92.9¶¶ | CES-D ≥20 | 21.7 | 15.5 | 25.4 | — |
2277a | 61.5 | — | — | 16.0‡ | 13.4 | 17.6 | — |
Data are means ± SD, unless otherwise indicated. T1 = type 1 diabetes, T2 = type 2 diabetes, n = sample size, PSE = Present State Examination, DIS/DSM-III = Diagnostic Interview Schedule/Diagnostic and Statistical Manual-III, GDS = Geriatric Depression Scale, Zung = Zung Self-Rating Depression Scale, CIS = Clinical Interview Schedule, CES-D = Center for Epidemiologic Studies-Depression Scale.
Sample randomly selected from a acommunity, bclinic or hospital, or cunspecified setting.
Sample not randomly selected from a dcommunity, eclinic or hospital, or funspecified setting.
P ≤ .001 vs. the prevalence of the overall or sex-specific diabetic group;
nonsignificant vs. the prevalence of the overall or sex-specific diabetic group;
P ≤ .05 vs. the prevalence of the overall or sex-specific diabetic group;
P ≤ .01 vs. the prevalence of the overall or sex-specific diabetic group;
age- and sex-adjusted;
age-adjusted;
these studies reported only mean depression scale scores for diabetic and nondiabetic subjects, and thus were not included in the prevalence calculations;
sex-adjusted;
greater (P < .001) in nondiabetic females vs. male counterparts;
prevalences are any affective disorder including major depression, dysthmia, and mania. Mania represented just 2% of all affective disorders in this study.
the number is the percentage of Caucasian subjects in the entire sample.